Thermo Fisher Scientific, Inc. (TMO)
Thermo Fisher Scientific Market Cap : 242.11B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 242.11B |
| October 01, 2026 | 241.26B |
| September 30, 2026 | 249.60B |
| September 29, 2026 | 251.28B |
| September 28, 2026 | 250.91B |
| September 25, 2026 | 249.58B |
| September 24, 2026 | 250.83B |
| September 23, 2026 | 245.99B |
| September 22, 2026 | 243.49B |
| September 21, 2026 | 243.57B |
| September 18, 2026 | 240.87B |
| September 17, 2026 | 243.41B |
| September 16, 2026 | 239.76B |
| September 15, 2026 | 237.15B |
| September 14, 2026 | 226.88B |
| September 11, 2026 | 225.48B |
| September 10, 2026 | 223.02B |
| September 09, 2026 | 223.95B |
| September 08, 2026 | 222.97B |
| September 04, 2026 | 226.94B |
| September 03, 2026 | 228.66B |
| September 02, 2026 | 225.01B |
| September 01, 2026 | 222.03B |
| August 31, 2026 | 228.17B |
| August 28, 2026 | 230.05B |
| Date | Value |
|---|---|
| August 27, 2026 | 233.20B |
| August 26, 2026 | 234.31B |
| August 25, 2026 | 232.26B |
| August 24, 2026 | 232.47B |
| August 21, 2026 | 232.67B |
| August 20, 2026 | 232.03B |
| August 19, 2026 | 226.85B |
| August 18, 2026 | 217.80B |
| August 17, 2026 | 216.49B |
| August 14, 2026 | 217.52B |
| August 13, 2026 | 220.33B |
| August 12, 2026 | 222.96B |
| August 11, 2026 | 223.70B |
| August 10, 2026 | 221.73B |
| August 07, 2026 | 219.63B |
| August 06, 2026 | 214.46B |
| August 05, 2026 | 213.65B |
| August 04, 2026 | 208.81B |
| August 03, 2026 | 212.25B |
| July 31, 2026 | 212.35B |
| July 30, 2026 | 213.26B |
| July 29, 2026 | 213.14B |
| July 28, 2026 | 213.13B |
| July 27, 2026 | 206.88B |
| July 24, 2026 | 210.11B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Agilent Technologies, Inc. | 47.31B |
| Danaher Corp. | 150.46B |
| Illumina, Inc. | 41.23B |
| Bio-Rad Laboratories, Inc. | 9.870B |
| Revvity, Inc. | 16.91B |
Market Cap Related Metrics
| PE Ratio | 35.22 |
| PS Ratio | 5.296 |
| PEG Ratio | 4.634 |
| Price to Book Value | 4.596 |
| Price to Free Cash Flow | 33.53 |
| Price | 654.80 |
| Earnings Yield | 2.84% |
| PEGY Ratio | 4.468 |
| Operating PE Ratio | 27.74 |
| Normalized PE Ratio | 34.21 |